# Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis

> **NCT03183245** · PHASE3 · COMPLETED · sponsor: **Humacyte, Inc.** · enrollment: 242 (actual)

## Conditions studied

- Renal Failure
- End Stage Renal Disease
- Hemodialysis
- Vascular Access

## Interventions

- **BIOLOGICAL:** Human Acellular Vessel (HAV)
- **PROCEDURE:** Arteriovenous fistula (AVF)
- **OTHER:** Hemodialysis

## Key facts

- **NCT ID:** NCT03183245
- **Lead sponsor:** Humacyte, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-29
- **Primary completion:** 2024-04-22
- **Final completion:** 2025-06-19
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03183245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03183245, "Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03183245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*